PAPER Hu D, Chen M, Li X, Daley S, Morin P, Han Y, Hemberg M, Weiner HL, Xia W

ApoE ε4-dependent Alteration of CXCR3 + CD127+ CD4+ T cells associates with elevated plasma neurofilament light chain in Alzheimer's disease.

J Alzheimers Dis. 2025 Mar 20;:13872877251320123. Epub 2025 Mar 20 PubMed.

Maura Marx

Fidelity Foundation
United States

Zita Salajkova

Fondazione Istituto Italiano di Tecnologia
Italy

PAPER Hao Y, Li Z, Du X, Xie Q, Li D, Lei S, Guo Y

Characterization and chemoproteomic profiling of protein O-GlcNAcylation in SOD1-G93A mouse model.

Mol Med. 2025 Feb 28;31(1):82. PubMed.

PAPER Zhu HX, Lou WW, Jiang YM, Ciobanu A, Fang CX, Liu CY, Yang YL, Cao JY, Shan L, Zhuang QX

Histamine Modulation of the Basal Ganglia Circuitry in the Motor Symptoms of Parkinson's Disease.

CNS Neurosci Ther. 2025 Feb;31(2):e70308. PubMed.

PAPER Müller E, Enzlein T, Niemeyer D, von Ammon L, Stumpo K, Biber K, Klein C, Hopf C

Exploring the Aβ Plaque Microenvironment in Alzheimer's Disease Model Mice by Multimodal Lipid-Protein-Histology Imaging on a Benchtop Mass Spectrometer.

Pharmaceuticals (Basel). 2025 Feb 13;18(2) PubMed.

PAPER Henningfield CM, Ngo M, Murray KM, Kwang NE, Tsourmas KI, Neumann J, Pashkutz ZA, Kawauchi S, Swarup V, Lane TE, MacGregor GR, Green KN

Generation of an Inducible Destabilized-Domain Cre Mouse Line to Target Disease Associated Microglia.

Glia. 2025 Feb 23; Epub 2025 Feb 23 PubMed.

PAPER Abbas K, Mustafa M, Alam M, Habib S, Ahmad W, Adnan M, Hassan MI, Usmani N

Multi-target approach to Alzheimer's disease prevention and treatment: antioxidant, anti-inflammatory, and amyloid- modulating mechanisms.

Neurogenetics. 2025 Apr 1;26(1):39. PubMed.

PAPER Mejia-Gutierrez M, Moser B, Pirlot M, Zhang H, Chumala P, Katselis GS, Palmer DR, Krol ES

Caffeine and Nicotine with N-Substituted Diazirine Photoaffinity Labels Form Adducts at Tyrosine-39 of α-Synuclein.

ACS Chem Neurosci. 2025 Apr 1; Epub 2025 Apr 1 PubMed.

PAPER Liu X, Zheng Z, Xue C, Wang X, Li J, Liu Z, Xin W, Xu X, Zhou D, Yao L, Lu G

LRRK2 Mediates α-Synuclein-Induced Neuroinflammation and Ferroptosis through the p62-Keap1-Nrf2 Pathway in Parkinson's Disease.

Inflammation. 2025 Apr 2; Epub 2025 Apr 2 PubMed.

PAPER Mao M, Zhou Y, Zhang H, Deng P, Yang J, Zhong J, Li N, Liu Q, Li X, Wu X, Cheng Y

Synthesis and identification of azocoumarin derivatives toward imaging of α-synuclein aggregates in the brain.

Eur J Med Chem. 2025 Mar 29;290:117587. Epub 2025 Mar 29 PubMed.

PAPER Fischer AL, Schmitz M, Thom T, Zafar S, Younas N, da Silva Correia S, da Silva Correia A, Eyyuboglu SC, Zerr I

Alpha-Synuclein Demonstrates Varying Binding Affinities With Different Tau Isoforms.

J Neurochem. 2025 Apr;169(4):e70053. PubMed.

PAPER Nemati R, Sohrabi-Ashlaghi A, Saberian P, Sadeghi M, Mardani S, Abadi AS, Yaghoobpoor A, Heydari A, Khoshroo N, Rahnama Y, Mayeli M, Nasiri H

Growth associated protein 43 (GAP-43) predicts brain amyloidosis in Alzheimer's dementia continuum: an [18 F] AV-45 study.

BMC Neurol. 2025 Apr 1;25(1):134. PubMed.

PAPER Yao L, Zhang Z

Lateralized Amplitude Low-frequency Fluctuation Alterations in Mild Cognitive Impairment as a Biomarker for Early Alzheimer's Disease Detection.

Acad Radiol. 2025 Mar 31; Epub 2025 Mar 31 PubMed.

PAPER Mandula SK, Nath S, Gogoi V

Intersection of pain and behavioural and psychological symptoms of dementia in Alzheimer's disease.

Psychogeriatrics. 2025 May;25(3):e70028. PubMed.